Hypera S.A. Sponsored ADR (HM6A)
XSTU
Real-time Data
06:00 AM
Day's Range
3.4852 wk Range
2.70Overview - HM6A - Hypera S.A. Sponsored ADR
Key Statistics
Valuation
Enterprise Value
1.36B
P/E (Trailing)
‪7.72‬
Price / Sales (TTM)
‪0.27‬
Price / Book
‪0.99‬
EV / EBITDA
‪3.03‬
Profitability
Gross Margin
‪61.78%‬
Profit Margin
‪19.82%‬
Operating Margin
‪28.82%‬
Return on Assets
‪6.32%‬
Return on Equity
‪13.16%‬
Ownership
Shares Outstanding
703.99M
Float
304.14M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.0080%‬
Price stats
Beta
‪0.10‬
50-Day Avg
‪3.42‬
200-Day Avg
‪3.57‬
Dividends
Payout Ratio
‪42.20%‬
Frequency
Quarterly
Peers - HM6A - Hypera S.A. Sponsored ADR
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XSTU.
- HM6AXSTUHypera S.A. Sponsored ADR2.35BMarket Cap+1.75%52-week change7.42P/E (Trailing)‪19.48%‬Profit Margin
- H6DXSTUHaleon Plc - ADR72.13BMarket Cap+2.35%52-week change23.61P/E (Trailing)‪64.18%‬Profit Margin
- MRKCXSTUMerck KGaA – Sponsored ADR59.12BMarket Cap+21.17%52-week change23.05P/E (Trailing)‪11.21%‬Profit Margin
- D8Y0XSTUSandoz Group AG ADR33.96BMarket Cap+32.05%52-week change62.80P/E (Trailing)‪5.53%‬Profit Margin
- 08HHXSTUShanghai Fosun Pharmaceutical Group Co., Ltd.4.97BMarket Cap-20.35%52-week change11.06P/E (Trailing)‪8.21%‬Profit Margin
- 41LXSTULaboratorios Farmacéuticos Rovi SA4.08BMarket Cap+7.72%52-week change119.22P/E (Trailing)‪64.92%‬Profit Margin
- 2TZXSTUTianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.1.66BMarket Cap-14.91%52-week change15.43P/E (Trailing)‪17.96%‬Profit Margin
Profile Summary - HM6A - Hypera S.A. Sponsored ADR
About
Hypera S.A. Sponsored ADR represents shares of Hypera S.A., a leading pharmaceutical company in Brazil. This American Depositary Receipt (ADR) allows U.S. investors to invest in Hypera without having to directly purchase the Brazilian shares. Hypera S.A. operates primarily in the pharmaceutical and healthcare sectors,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
